Top compounds associated with response to RNF165

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	alisertib:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.2	2e-06
mRNA	PX-12	CTRPv2	pan-cancer	AAC	0.16	4e-06
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.25	5e-06
mRNA	GSK1070916	GDSC1000	pan-cancer	AAC	0.14	1e-05
mRNA	BRD-K34222889	CTRPv2	pan-cancer	AAC	0.16	3e-05
mRNA	GSK1120212	CTRPv2	pan-cancer	AAC	-0.25	3e-05
mRNA	WZ3105	GDSC1000	pan-cancer	AAC	0.13	3e-05
mRNA	alisertib	CTRPv2	pan-cancer	AAC	0.15	4e-05
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	4e-05
mRNA	selumetinib:BRD-A02303741 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.17	5e-05

Download CSV